Pseudoangiomatous stromal hyperplasia (PASH) of the breast: A series of 24 patients

Breast Journal

Volumn 18, Issue 3, 2012, Pages 242-247

  Bowman, Erin ^a,c   Oprea, Gabriela ^b,c   Okoli, Joel ^a,c   Gundry, Kathleen ^b,c   Rizzo, Monica ^b,c   Gabram Mendola, Sheryl ^b,c   Manne, Upender ^d   Smith, Geoffrey ^b,c   Pambuccian, Stefan ^e   Bumpers, Harvey L ^a,c  

^a MOREHOUSE SCHOOL OF MEDICINE   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c GRADY MEMORIAL HOSPITAL   (United States)

^d University of Alabama at Birmingham   (United States)

^e UNIVERSITY OF MINNESOTA   (United States)

Author keywords

breast tumor; PASH; pseudoangiomatous; stromal hyperplasia

Indexed keywords

ESTROGEN RECEPTOR; MONOCLONAL ANTIBODY D2-40; PROGESTERONE RECEPTOR;

ADULT; AGED; ATYPICAL DUCTAL HYPERPLASIA; ATYPICAL LOBULAR DYSPLASIA; BREAST BIOPSY; BREAST CANCER; BREAST DISCHARGE; BREAST DYSPLASIA; BREAST FIBROSIS; BREAST HYPERPLASIA; CLINICAL ARTICLE; ECHOGRAPHY; EXCISION; FAMILY HISTORY; FEMALE; FOLLOW UP; GYNECOMASTIA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; MAMMOGRAPHY; MASTALGIA; MEDICAL RECORD REVIEW; NEEDLE BIOPSY; POSTMENOPAUSE; PREMENOPAUSE; PSEUDOANGIOMATOUS STROMAL HYPERPLASIA; REVIEW; TUMOR VOLUME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANGIOMATOSIS; BREAST; BREAST DISEASES; BREAST NEOPLASMS; CARCINOMA, INTRADUCTAL, NONINFILTRATING; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERPLASIA; MALE; MAMMOGRAPHY; MIDDLE AGED; PERIMENOPAUSE; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84861144980     PISSN: 1075122X     EISSN: 15244741     Source Type: Journal    
DOI: 10.1111/j.1524-4741.2012.01230.x     Document Type: Review

References (22)

1. Vuitch MF, Rosen PP, Erlandson RA,. Pseudoangiomatous hyperplasia of mammary stroma. Hum Pathol 1986; 17: 185-91. (Pubitemid 16004695)
2. Wieman SM, Landercasper J, Johnson JM, et al. Tumoral pseudoangiomatous stromal hyperplasia of the breast. Am Surg 2008; 74: 1211-4.
3. Ibrahim RE, Sciotto CG, Weidner N,. Pseudoangiomatous hyperplasia of mammary stroma. Some observations regarding its clinicopathologic spectrum. Cancer 1989; 63: 1154-60. (Pubitemid 19074747)
4. Fisher CJ, Hanby AM, Robinson L, Millis RR,. Mammary hamartoma-a review of 35 cases. Histopathology 1992; 20: 99-106.
5. Shehata BM, Fishman I, Collings MH, et al. Pseudoangiomatous stromal hyperplasia of the breast in pediatric patients: an underrecognized entity. Pediatr Dev Pathol 2009; 12: 450-4.
6. Hargaden GC, Yeh ED, Georgian-Smith D, et al. Analysis of the mammographic and sonographic features of pseudoangiomatous stromal hyperplasia. AJR Am J Roentgenol 2008; 191: 359-63.
7. Celliers L, Wong DD, Bourke A,. Pseudoangiomatous stromal hyperplasia: a study of the mammographic and sonographic features. Clin Radiol 2010; 65: 145-9.
8. Jones KN, Glazebrook KN, Reynolds C,. Pseudoangiomatous stromal hyperplasia: imaging findings with pathologic and clinical correlation. AJR Am J Roentgenol 2010; 195: 1036-42.
9. Pruthi S, Reynolds C, Johnson RE, Gisvold JJ,. Tamoxifen in the management of pseudoangiomatous stromal hyperplasia. Breast J 2001; 7: 434-9. (Pubitemid 34024469)
10. Seltzer MH, Kintiroglou M,. Pseudoangiomatous hyperplasia and response to tamoxifen therapy. Breast J 2003; 9: 344. (Pubitemid 36927426)
11. AbdullGaffar B,. Pseudoangiomatous stromal hyperplasia of the breast. Arch Pathol Lab Med 2009; 133: 1335-8.
12. Ferreira M, Albarracin CT, Resetkova E,. Pseudoangiomatous stromal hyperplasia tumor: a clinical, radiologic and pathologic study of 26 cases. Mod Pathol 2008; 21: 201-7. (Pubitemid 351172172)
13. Degnim AC, Frost MH, Radisky DC, et al. Pseudoangiomatous stromal hyperplasia and breast cancer risk. Ann Surg Oncol 2010; 17: 3269-77.
14. Gresik CM, Godellas C, Aranha GV, Rajan P, Shoup M,. Pseudoangiomatous stromal hyperplasia of the breast: a contemporary approach to its clinical and radiologic features and ideal management. Surgery 2010; 148: 752-7. discussion 757-8.
15. Anderson C, Ricci A Jr, Pedersen CA, Cartun RW,. Immunocytochemical analysis of estrogen and progesterone receptors in benign stromal lesions of the breast. Evidence for hormonal etiology in pseudoangiomatous hyperplasia of mammary stroma. Am J Surg Pathol 1991; 15: 145-9.
16. Powell CM, Cranor ML, Rosen PP,. Pseudoangiomatous stromal hyperplasia (PASH). A mammary stromal tumor with myofibroblastic differentiation. Am J Surg Pathol 1995; 19: 270-7.
17. Zanella M, Falconieri G, Lamovec J, Bittesini L,. Pseudoangiomatous hyperplasia of the mammary stroma: true entity or phenotype? Pathol Res Pract 1998; 194: 535-40. (Pubitemid 28430072)
18. Badve S, Sloane JP,. Pseudoangiomatous hyperplasia of male breast. Histopathology 1995; 26: 463-6.
19. Milanezi MF, Saggioro FP, Zanati SG, Bazan R, Schmitt FC,. Pseudoangiomatous hyperplasia of mammary stroma associated with gynaecomastia. J Clin Pathol 1998; 51: 204-6. (Pubitemid 28216075)
20. Glazebrook KN, Magut MJ, Reynolds C,. Angiosarcoma of the breast. AJR Am J Roentgenol 2008; 190: 533-8. (Pubitemid 351196628)
21. Damiani S, Eusebi V, Peterse JL,. Malignant neoplasms infiltrating pseudoangiomatous' stromal hyperplasia of the breast: an unrecognized pathway of tumour spread. Histopathology 2002; 41: 208-15. (Pubitemid 35013942)
22. Nassar H, Elieff MP, Kronz JD, Argani P,. Pseudoangiomatous stromal hyperplasia (PASH) of the breast with foci of morphologic malignancy: a case of pash with malignant transformation? Int J Surg Pathol 2008; 18: 564-9.